Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

An integrated approach to uncover driver genes in breast cancer methylation genomes.

Shen X, Li S, Zhang L, Li H, Hong G, Zhou X, Zheng T, Zhang W, Hao C, Shi T, Liu C, Guo Z.

PLoS One. 2013 Apr 8;8(4):e61214. doi: 10.1371/journal.pone.0061214.

2.

Determining the effect of DNA methylation on gene expression in cancer cells.

Lee CJ, Evans J, Kim K, Chae H, Kim S.

Methods Mol Biol. 2014;1101:161-78. doi: 10.1007/978-1-62703-721-1_9.

PMID:
24233782
3.

Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.

Minning C, Mokhtar NM, Abdullah N, Muhammad R, Emran NA, Ali SA, Harun R, Jamal R.

Int J Oncol. 2014 Nov;45(5):1959-68. doi: 10.3892/ijo.2014.2625.

PMID:
25175708
4.

Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.

Park SY, Kwon HJ, Choi Y, Lee HE, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH.

Mod Pathol. 2012 Feb;25(2):185-96. doi: 10.1038/modpathol.2011.160.

5.

Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.

Rodenhiser DI, Andrews J, Kennette W, Sadikovic B, Mendlowitz A, Tuck AB, Chambers AF.

Breast Cancer Res. 2008;10(4):R62. doi: 10.1186/bcr2121.

6.

Prediction of epigenetically regulated genes in breast cancer cell lines.

Loss LA, Sadanandam A, Durinck S, Nautiyal S, Flaucher D, Carlton VE, Moorhead M, Lu Y, Gray JW, Faham M, Spellman P, Parvin B.

BMC Bioinformatics. 2010 Jun 4;11:305. doi: 10.1186/1471-2105-11-305.

7.

Development of a novel approach, the epigenome-based outlier approach, to identify tumor-suppressor genes silenced by aberrant DNA methylation.

Kikuyama M, Takeshima H, Kinoshita T, Okochi-Takada E, Wakabayashi M, Akashi-Tanaka S, Ogawa T, Seto Y, Ushijima T.

Cancer Lett. 2012 Sep 28;322(2):204-12. doi: 10.1016/j.canlet.2012.03.016.

PMID:
22433712
8.

DNA methylation epigenotypes in breast cancer molecular subtypes.

Bediaga NG, Acha-Sagredo A, Guerra I, Viguri A, Albaina C, Ruiz Diaz I, Rezola R, Alberdi MJ, Dopazo J, Montaner D, Renobales M, Fernández AF, Field JK, Fraga MF, Liloglou T, de Pancorbo MM.

Breast Cancer Res. 2010;12(5):R77. doi: 10.1186/bcr2721.

9.

An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.

Holm K, Staaf J, Lauss M, Aine M, Lindgren D, Bendahl PO, Vallon-Christersson J, Barkardottir RB, Höglund M, Borg Å, Jönsson G, Ringnér M.

Breast Cancer Res. 2016 Feb 29;18(1):27. doi: 10.1186/s13058-016-0685-5.

10.

DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.

Roll JD, Rivenbark AG, Jones WD, Coleman WB.

Mol Cancer. 2008 Jan 25;7:15. doi: 10.1186/1476-4598-7-15.

11.

Differential methylation hybridization profiling identifies involvement of STAT1-mediated pathways in breast cancer.

Kim JH, Kang HS, Kim TW, Kim SJ.

Int J Oncol. 2011 Oct;39(4):955-63. doi: 10.3892/ijo.2011.1075.

PMID:
21674123
12.

Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.

Li Y, Li S, Chen J, Shao T, Jiang C, Wang Y, Chen H, Xu J, Li X.

Hum Mol Genet. 2014 Oct 15;23(20):5378-93. doi: 10.1093/hmg/ddu256.

PMID:
24871326
13.

Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.

Rubinstein JC, Tran N, Ma S, Halaban R, Krauthammer M.

BMC Med Genomics. 2010 Feb 9;3:4. doi: 10.1186/1755-8794-3-4.

14.

A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.

Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, Wong M, Shyr Y, Nanda R, Olopade OI, Gerald W, Euhus DM, Shay JW, Gazdar AF, Minna JD.

PLoS Med. 2006 Dec;3(12):e486.

15.

DBCAT: database of CpG islands and analytical tools for identifying comprehensive methylation profiles in cancer cells.

Kuo HC, Lin PY, Chung TC, Chao CM, Lai LC, Tsai MH, Chuang EY.

J Comput Biol. 2011 Aug;18(8):1013-7. doi: 10.1089/cmb.2010.0038.

PMID:
21214365
16.
17.

Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns.

Holm K, Hegardt C, Staaf J, Vallon-Christersson J, Jönsson G, Olsson H, Borg A, Ringnér M.

Breast Cancer Res. 2010;12(3):R36. doi: 10.1186/bcr2590.

18.

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y.

Cancer Res. 2003 Jul 15;63(14):4174-80.

19.

Epigenetic alteration of the NF-κB-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer.

Yamamoto M, Ito T, Shimizu T, Ishida T, Semba K, Watanabe S, Yamaguchi N, Inoue J.

Cancer Sci. 2010 Nov;101(11):2391-7. doi: 10.1111/j.1349-7006.2010.01685.x.

20.

Methylation subtypes and large-scale epigenetic alterations in gastric cancer.

Zouridis H, Deng N, Ivanova T, Zhu Y, Wong B, Huang D, Wu YH, Wu Y, Tan IB, Liem N, Gopalakrishnan V, Luo Q, Wu J, Lee M, Yong WP, Goh LK, Teh BT, Rozen S, Tan P.

Sci Transl Med. 2012 Oct 17;4(156):156ra140. doi: 10.1126/scitranslmed.3004504.

Supplemental Content

Support Center